Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine
Condition: Parkinson's Disease Interventions: Drug: Pimavanserin; Other: Placebo; Drug: Quetiapine Sponsor: ACADIA Pharmaceuticals Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials